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Higher brain functions that rely on attention and reward
seeking depend on the integrity of neuromodulatory sys-
tems using dopamine (DA) and noradrenaline (NA).
Despite the importance for these neuromodulators, there
have been no direct experimental comparisons of the
selectivity of DA and NA neurons, so making statements
about the differences in functionality are speculative. We
have recorded activity from dopamine neurons of the
substantia nigra pars compacta and noradraline neurons
of the locus coeruleus in monkeys while the monkeys
carried out a visually-cued reward schedule task.In this
task, the monkeys perform schedules of 1, 2, or 3 red-to-
green sequential color discrimination trials to earn a
reward. A cue presented at the beginning of each trial
shows how many trials must yet be completed to obtain
a reward. Error rates increase in this simple task as the
number of trials yet to be performed before a reward
increase, even though the red-green discrimination is
identical in every trial, indicating that the reward value is
discounted as a function of trials remaining before
reward (at type of temporal discounting). We also find lip
movements that occur when cue appears and at bar
release (bar release is the correct response to a red-
>green color change). The lipping at the cue occurs
whenever a new schedule begins, and is not related to the
number of trials to be carried out. At bar release, lipping
is strongest in rewarded trials. We interpret the lipping
as reflecting the value of the event at that instant. Both
DA and NA neurons seem to reflect the lipping response,
with responses occurring when the cue appears in first
trials, and at the time of bar-release. The neuronal
responses that occur when the cue appears are similar,
with both DA and NA neurons showing activations in
the first trial of a schedule. At bar release, however, the
activity furthest from reward is largest for NA neurons,
whereas for DA neurons the greatest activity occurs in
the rewarded trials.
Our data lead us to suggest that both systems are
simultaneously evaluating the subjective or perceived
value of the current state, but in different ways. We sug-
gest that the noraderaline system reflects the cost of the
current behavior, the cost being higher when the reward
is more distant, and the dopamine system reflects the
current expected benefit. In a neuroeconomic framework,
these two catecholamine systems, almost certainly
evolved from a common ancestor, have diverged to
represent costs and benefits, for NA and DA, respec-
tively. We speculate that the interaction between these
two neuromodulatory systems is critical to motivate
value-based behavior, and intimate knowledge of the
dynamic balance between them is required to model the
motivation underlying higher reward seeking activity.
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